C1q, a complement factor in the classical innate immune pathway, and the dysregulation of complement proteins and cytokines has been demonstrated in many CNS disorders, including epilepsy31, 32 and neurodegenerative diseases33, 34, 35. This evidence concerns the gene VTN and central nervous system disorder.